Tracking the PDSB option chain helps you see every strike and expiry on PDS Biotechnology Corp in one view, so you can quickly identify the contracts that fit your thesis and your risk. PDS Biotechnology Corp's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of PDSB options activity at a glance. Use our scanner to monitor the PDSB option chain in real time and filter for the PDSB options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For PDSB stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the PDSB option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where PDSB stock options are being actively traded and where they are not.
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma.
In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls PDS Biotechnology Corp's full chain across every expiry, highlights the most liquid strikes, and lets you screen PDSB options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of PDSB stock options — let the full option chain come to you, pre-filtered and ready to trade.
